Entity information:

• Entity registrant name: Insys Therapeutics, Inc.
• CIK: 0001516479
• SEC filing page: http://www.sec.gov/Archives/edgar/data/1516479/000156459018005187/0001564590-18-005187-index.htm
• XBRL Instance: http://www.sec.gov/Archives/edgar/data/1516479/000156459018005187/insy-20171231.xml
• XBRL Cloud Viewer: https://edgardashboard.xbrlcloud.com/flex/viewer/XBRLViewer.html#instance=http://www.sec.gov/Archives/edgar/data/1516479/000156459018005187/insy-20171231.xml
• EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001516479
• Generator: Donnelley Financial Solutions
• Total assets: 279,080,000
• Income tax expense (benefit): 10,820,000
• Found reconcilation from statutory to effective rates: True
• Found income tax policy: Coming soon!

---